Cue Health to Provide Highly-Accurate, Molecular COVID-19 Tests to Johns Hopkins Medicine

(US and Canada) Cue Health, a healthcare technology company, announced it will provide Cue Health Monitoring Systems and Cue COVID-19 tests to Johns Hopkins Medicine (JHM), which includes Johns Hopkins University School of Medicine and The Johns Hopkins Hospital and Health System.

The portable monitoring system and tests will be utilized by physicians, scientists, health professionals, faculty and staff as part of JHM's commitment to health and well-being among its entire employee population. In addition, JHM will have access to a Cue Health Enterprise Dashboard, which allows for test results to be shared through a secure, web-based internal application. This helps organizations manage population health and access timely data and analytics to enable administrators to swiftly identify trends and make informed decisions.

Cue's test uses molecular nucleic acid amplification technology (NAAT) and is the most accurate* self-test for COVID-19, providing lab-quality results directly to connected mobile devices in 20 minutes. The test is able to detect all known COVID-19 variants, including Omicron, and can be used on adults and children (age 2 years and over for OTC/home use and under 2 for professional use), with or without symptoms.

"Johns Hopkins Medicine is playing a leading and critical role in the fight against COVID-19, and we are honored to help support their team's health and well-being," said Ayub Khattak, Co-Founder and CEO of Cue. "In settings like hospitals and medical research facilities, accuracy cannot be compromised and precision is paramount. That's why world-class healthcare organizations like Johns Hopkins Medicine turn to Cue. We provide the confidence in self-testing and access to real-time health information that's highly valued for those on the frontlines of this pandemic."

Johns Hopkins Medicine is one of several healthcare-affiliated organizations to which Cue provides its tests, including internationally-recognized hospital systems throughout the U.S.. Cue also provides tests to Google, the National Basketball Association, and Major League Baseball, among other organizations.

*Based on clinical study results submitted to FDA for other EUA molecular home tests.